What's fair: ICER re­port finds in­sur­er cov­er­age typ­i­cal­ly meets ac­cess cri­te­ria for 18 pre­scrip­tion drugs

Drug pric­ing watch­dog ICER on Fri­day un­veiled its third an­nu­al score­card on how “fair­ly” sev­er­al US in­sur­ers and PBMs cov­ered 18 pre­scrip­tion drugs across 19 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER